Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma. | Front Immunol | 2022 | 36618348 | PubTator, text mining | PubMed |
| Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations. | Int J Mol Sci | 2022 | 36613817 | PubTator, text mining | PubMed |
| The Multiple Roles of Periostin in Non-Neoplastic Disease. | Cells | 2022 | 36611844 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma. | Front Oncol | 2022 | 36591519 | PubTator, text mining | PubMed |
| Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma. | Front Pharmacol | 2022 | 36588677 | PubTator, text mining | PubMed |
| Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients' survival. | Ther Adv Med Oncol | 2022 | 36579028 | PubTator, text mining | PubMed |
| High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma. | BMC Cancer | 2022 | 36575439 | PubTator, text mining | PubMed |
| Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment. | Sci Rep | 2022 | 36572780 | PubTator, text mining | PubMed |
| Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis. | Front Immunol | 2022 | 36569924 | PubTator, text mining | PubMed |
| Transcriptome Profiling in Swine Macrophages Infected with African Swine Fever Virus (ASFV) Uncovers the Complex and Close Relationship with Host. | Pathogens | 2022 | 36558746 | PubTator, text mining | PubMed |
| Tissue-Protective and Anti-Inflammatory Landmark of PRP-Treated Mesenchymal Stromal Cells Secretome for Osteoarthritis. | Int J Mol Sci | 2022 | 36555578 | PubTator, text mining | PubMed |
| Apple Derived Exosomes Improve Collagen Type I Production and Decrease MMPs during Aging of the Skin through Downregulation of the NF-κB Pathway as Mode of Action. | Cells | 2022 | 36552714 | PubTator, text mining | PubMed |
| Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis. | Ann Transl Med | 2022 | 36544675 | PubTator, text mining | PubMed |
| Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma. | Sci Rep | 2022 | 36543847 | PubTator, text mining | PubMed |
| Biomarkers in psoriatic arthritis: A meta-analysis and systematic review. | Front Immunol | 2022 | 36532039 | PubTator, text mining | PubMed |
| New insights into immunomodulatory properties of lactic acid bacteria fermented herbal medicines. | Front Microbiol | 2022 | 36519164 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors. | PeerJ | 2022 | 36518297 | PubTator, text mining | PubMed |
| The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma. | Front Oncol | 2022 | 36505882 | PubTator, text mining | PubMed |
| Identification and experimental validation of a tumor-infiltrating lymphocytes-related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma. | Front Immunol | 2022 | 36505457 | PubTator, text mining | PubMed |
| Human gut microbiota-reactive DP8α regulatory T cells, signature and related emerging functions. | Front Immunol | 2022 | 36479125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=25